27 Oct 2021 --- US-based Aptar Group has received approval from the US Food and Drug Administration (FDA) for its patented Cartridge Pump System (CPS) as a nasal delivery system for dry eye syndrome. Oyster Point Pharma, a biopharmaceutical company specializing in ophthalmology, uses CPS for its Tyrvaya Varenicline solution, the only nasal spray approved to treat the signs and symptoms of dry eye disease.
